By living within the matrix of mitochondria, members of the ferromanganese SOD2 may be able to inhibit ferroptosis in non-small cell lung cancer (NSCLC) cells prompted by mitochondrial ROS (Zhao et al., 2023). The gene discussed is SOD2; the disease is non-small cell lung carcinoma.